Critical Care & Emergencies (all articles)
[Abstract Only] Randomized trial: Dexmedetomidine does not decrease postoperative atrial arrhythmias or delirium in patients recovering from cardiac surgery
21 Jul, 2020 | 09:16h | UTC
Related Commentary on Twitter
https://twitter.com/NydahlPeter/status/1285199896958644231
Guideline: Diagnosing acute aortic syndrome
21 Jul, 2020 | 09:18h | UTCCommentary: New guideline can help clinicians identify hard-to-diagnose acute aortic syndrome – News Medical
Podcast on acute kidney injury: myths & musings
21 Jul, 2020 | 08:59h | UTC#226 Kidney Boy on Acute Kidney Injury: Myths & Musings – The Curbsiders Internal Medicine Podcast
Randomized trial: dexamethasone in hospitalized patients with Covid-19
20 Jul, 2020 | 08:18h | UTCCommentary: Trial data support dexamethasone, but not hydroxychloroquine, for COVID-19 – CIDRAP
Related Commentary on Twitter
A randomized controlled trial testing dexamethasone for Covid-19 (the RECOVERY trial) showed that, compared with usual care, this corticosteroid drug reduced 28-day mortality in hospitalized patients. #COVID19 #SARSCoV2
— NEJM (@NEJM) July 18, 2020
The role of chest radiography in confirming Covid-19 pneumonia
20 Jul, 2020 | 08:13h | UTCThe role of chest radiography in confirming covid-19 pneumonia – The BMJ
Related Commentary on Twitter
"No single feature of covid-19 pneumonia on a chest radiograph is specific or diagnostic, but a combination of multifocal peripheral lung changes of ground glass opacity and/or consolidation, which are most commonly bilateral, may be present."#BMJEducation https://t.co/22nRTBVxmj
— The BMJ (@bmj_latest) July 19, 2020
COVID-19 in people with diabetes: understanding the reasons for worse outcomes
20 Jul, 2020 | 08:06h | UTCRelated: New-Onset Diabetes in Covid-19 – New England Journal of Medicine
Related Commentary on Twitter
#New #COVID19 content: Stefano Del Prato & colleagues review: #COVID-19 in people with #diabetes: understanding the reasons for worse outcomes https://t.co/7eYPmdsgvE pic.twitter.com/y9EmhG8Rsv
— The Lancet Diabetes & Endocrinology (@TheLancetEndo) July 18, 2020
Review: clinical presentation and management of COVID ‐19
20 Jul, 2020 | 07:51h | UTCClinical presentation and management of COVID ‐19 – Medical Journal of Australia
The Zentensivist manifesto. Defining the art of critical care
20 Jul, 2020 | 07:42h | UTCThe Zentensivist Manifesto. Defining the Art of Critical Care – ATS Scholar
Source: Grupo UTIclínica – HCFMUSP
[Abstract Only] Randomized trial: urgent endoscopic retrograde cholangiopancreatography with sphincterotomy vs. conservative treatment in predicted severe acute gallstone pancreatitis
20 Jul, 2020 | 07:44h | UTC
Related Commentary on Twitter
Routine or on-demand ERCP in pred severe biliary #pancreatitis? APEC trial today @TheLancet: major complications 38%/117 pts urgent ERCP incl sphincterotomy vs 44%/113 pts with ERCP on-demand. ERCP can be reserved for cholangitis/ persistent cholestasis. https://t.co/kz1jfTQIf8 pic.twitter.com/ZfkARKwvGv
— Marc Besselink (@MarcBesselink) July 17, 2020
Palliative care for patients with severe Covid-19
17 Jul, 2020 | 08:51h | UTCPalliative care for patients with severe covid-19 – The BMJ
RIP Hydroxychloroquine? 2 studies show no benefit in early/mild COVID-19
17 Jul, 2020 | 08:59h | UTCCommentaries: New Covid-19 study, despite flaws, adds to case against hydroxychloroquine – STAT AND Hydroxychloroquine also doesn’t help Covid-19 patients who aren’t hospitalized, new study finds – CNN
Review: Perioperative management of oral glucose-lowering drugs in the patient with Type 2 Diabetes
17 Jul, 2020 | 08:24h | UTC
[Preprint] RECOVERY trial: effect of hydroxychloroquine in hospitalized patients with COVID-19
16 Jul, 2020 | 08:39h | UTC
Related Commentary on Twitter (Thread – Click for more)
HYDROXYCHLOROQUINE – Recovery trial results finally out – and hopefully puts nail in coffin. Out of 4700 people randomized… HCQ did NOT lower #covid19 mortality. It anything it was trending in wrong direction. Thread 🧵 https://t.co/6Iu0NEejON pic.twitter.com/6l85Nmz4id
— Eric Feigl-Ding (@DrEricDing) July 15, 2020
Covid-19: experts criticize claim that remdesivir cuts death rates
16 Jul, 2020 | 08:31h | UTCCovid-19: Experts criticise claim that remdesivir cuts death rates – The BMJ
Related Commentary on Twitter
Experts have criticised pharmaceutical firm Gilead Sciences after it released data suggesting that its antiviral drug remdesivir can reduce death rates for patients with covid-19. They say the research is intrinsically flawed @MartinLandray https://t.co/a1q2FxMa7C
— The BMJ (@bmj_latest) July 14, 2020
Hematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19
16 Jul, 2020 | 08:24h | UTCCommentary: Coagulation disorder in COVID-19 – The Lancet Haematology
Related Commentary on Twitter
NEW research—Results of a retrospective study including 380 patients with #COVID19 admitted to Wuhan Union Hospital explores haematological characteristics and related risk factors https://t.co/lbDVw5lFBC pic.twitter.com/0qlvHzfzhR
— The Lancet Haematology (@TheLancetHaem) July 11, 2020
[Abstract Only] Randomized trial: ticagrelor and aspirin vs. aspirin alone in acute ischemic stroke or TIA
16 Jul, 2020 | 08:17h | UTCCommentaries: Acute Stroke or Transient Ischaemic Attack Treated With Ticagrelor and ASA for Prevention of Stroke and Death – THALES – American College of Cardiology AND Ticagrelor and aspirin taken post stroke may decrease the risk of recurrent stroke – 2 Minute Medicine
[Abstract Only] Randomized trial: timing of initiation of renal-replacement therapy in acute kidney injury
16 Jul, 2020 | 08:18h | UTC
ACC Consensus on management of anticoagulant-related bleeding
15 Jul, 2020 | 08:12h | UTCKey Points: ACC Consensus on Management of Anticoagulant-Related Bleeding
Researchers develop COVID-19 mortality risk calculator
14 Jul, 2020 | 08:33h | UTCResearchers develop COVID-19 mortality risk calculator – News Medical
Original Study [Preprint]: COVID-19 Mortality Risk Assessment: An International Multi-Center Study – medRxiv
See Calculator: COVID Analytics
Related Commentary on Twitter
Our team developed and validated a new COVID-19 mortality risk score using data from 33 hospitals across four different countries. I am very proud of this international collaboration. The paper is now available on medrxiv: https://t.co/VGEPJYqbEf
— Agni Orfanoudaki (@AgniOrfanoudaki) July 10, 2020
Guideline executive summary: therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections
14 Jul, 2020 | 08:11h | UTC
Review: Pathophysiology, Transmission, Diagnosis, and Treatment of COVID-19
13 Jul, 2020 | 00:29h | UTC
Review: Extrapulmonary Manifestations of COVID-19
13 Jul, 2020 | 00:28h | UTCExtrapulmonary manifestations of COVID-19 – Nature Medicine
Related review: Extra‐pulmonary complications of COVID‐19: a multi‐system disease? – Journal of Medical Virology
Updated Systematic Review: Convalescent Plasma or Hyperimmune Immunoglobulin for COVID‐19
13 Jul, 2020 | 00:13h | UTCCommentary: Convalescent plasma to treat people with COVID-19: the evidence so far – Evidently Cochrane
Related Commentary on Twitter
https://twitter.com/CochraneUK/status/1281613914296516608
Case Reports: 2 Adults with Kawasaki-like Multisystem Inflammatory Syndrome Associated with COVID-19
13 Jul, 2020 | 00:05h | UTCCase Report 1: An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19 – The Lancet
Case Report 2: An adult presentation consistent with PIMS-TS – The Lancet Rheumatology
Related Commentary on Twitter
First reports of Kawasaki-like #SARSCoV2 multi-system inflammatory syndrome in adultshttps://t.co/FYNWlxdk9q @TheLancet https://t.co/lnHMUxA7Ux @TheLancetRheum
21 yo in London, 45 yo in New York City pic.twitter.com/lLmSRzBjs4— Eric Topol (@EricTopol) July 11, 2020
Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke
13 Jul, 2020 | 00:03h | UTC